Slate Path Capital LP - Q2 2014 holdings

$3.58 Billion is the total value of Slate Path Capital LP's 18 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 84.6% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRcall$1,781,052,0009,100,000
+100.0%
49.78%
SPY NewSPDR S&P 500 ETF TRput$362,082,0001,850,000
+100.0%
10.12%
QQQ NewPOWERSHARES QQQ TRUSTput$234,775,0002,500,000
+100.0%
6.56%
CHTR SellCHARTER COMMUNICATIONS INC Dcl a new$144,126,000
-2.1%
910,000
-23.8%
4.03%
-63.8%
ISRG NewINTUITIVE SURGICAL INC$129,305,000314,000
+100.0%
3.61%
GOLD SellBARRICK GOLD CORP$128,594,000
-9.8%
7,027,000
-12.2%
3.59%
-66.7%
P SellPANDORA MEDIA INC$112,838,000
-22.9%
3,825,000
-20.7%
3.15%
-71.5%
AIG SellAMERICAN INTL GROUP INC$106,977,000
-20.8%
1,960,000
-27.4%
2.99%
-70.7%
SIRI  SIRIUS XM HLDGS INC$100,132,000
+8.1%
28,940,0000.0%2.80%
-60.1%
CTRP SellCTRIP COM INTL LTD$93,819,000
-41.1%
1,465,000
-53.6%
2.62%
-78.3%
ALLE NewALLEGION PUB LTD CO$93,522,0001,650,000
+100.0%
2.61%
ENDP SellENDO INTL PLC$77,722,000
-48.9%
1,110,000
-49.9%
2.17%
-81.1%
YOKU NewYOUKU TUDOU INCsponsored adr$52,611,0002,205,000
+100.0%
1.47%
PBF  PBF ENERGY INCcl a$37,843,000
+3.3%
1,420,0000.0%1.06%
-61.8%
MPC SellMARATHON PETE CORP$37,864,000
-62.8%
485,000
-58.5%
1.06%
-86.3%
ALNY BuyALNYLAM PHARMACEUTICALS INC$37,776,000
+36.7%
598,000
+45.3%
1.06%
-49.5%
QCOR NewQUESTCOR PHARMACEUTICALS INCput$34,221,000370,000
+100.0%
0.96%
CLF NewCLIFFS NAT RES INC$12,868,000855,000
+100.0%
0.36%
ARIA ExitARIAD PHARMACEUTICALS INC$0-6,620,000
-100.0%
-4.04%
ZNGA ExitZYNGA INCcl a$0-13,121,148
-100.0%
-4.27%
LNG ExitCHENIERE ENERGY INC$0-1,270,000
-100.0%
-5.32%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q2 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings